RANK Ligand Blocking Activity
- Name
- RANK Ligand Blocking Activity
- Accession Number
- DBCAT004389
- Description
Not Available
- Drugs
Drug Drug Description Denosumab A RANK ligand (RANKL) inhibitor used for the management of osteoporosis in patients at high risk for bone fractures. - Drugs & Drug Targets
Drug Target Type Denosumab Tumor necrosis factor ligand superfamily member 11 target